Your browser is no longer supported. Please, upgrade your browser.
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E16.85 EPS (ttm)2.40 Insider Own0.20% Shs Outstand2.50B Perf Week2.43%
Market Cap99.74B Forward P/E13.12 EPS next Y3.08 Insider Trans0.00% Shs Float2.48B Perf Month6.23%
Income6.05B PEG4.11 EPS next Q0.81 Inst Own13.10% Short Float0.68% Perf Quarter0.80%
Sales45.37B P/S2.20 EPS this Y23.20% Inst Trans0.15% Short Ratio4.44 Perf Half Y7.79%
Book/sh8.48 P/B4.77 EPS next Y7.81% ROA5.50% Target Price47.34 Perf Year14.34%
Cash/sh1.99 P/C20.30 EPS next 5Y4.10% ROE29.70% 52W Range33.26 - 42.68 Perf YTD9.84%
Dividend2.17 P/FCF65.51 EPS past 5Y-7.90% ROI17.30% 52W High-1.77% Beta0.69
Dividend %5.37% Quick Ratio0.50 Sales past 5Y7.30% Gross Margin67.70% 52W Low26.05% ATR0.46
Employees94066 Current Ratio0.80 Sales Q/Q6.10% Oper. Margin19.10% RSI (14)77.16 Volatility0.84% 1.02%
OptionableYes Debt/Eq1.66 EPS Q/Q-38.80% Profit Margin13.30% Rel Volume2.44 Prev Close40.42
ShortableYes LT Debt/Eq1.33 EarningsOct 27 BMO Payout50.30% Avg Volume3.78M Price41.92
Recom2.00 SMA207.65% SMA505.71% SMA2009.13% Volume4,265,811 Change3.72%
Jun-24-21Upgrade Deutsche Bank Sell → Hold
Mar-23-21Downgrade SVB Leerink Outperform → Mkt Perform
Feb-04-21Downgrade Deutsche Bank Hold → Sell
Jan-20-21Downgrade Credit Suisse Neutral → Underperform
Jan-15-21Initiated Deutsche Bank Hold
Nov-02-20Upgrade Liberum Hold → Buy
Sep-29-20Initiated Berenberg Buy
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-28-21 10:16AM  
08:35AM  
Oct-27-21 09:31PM  
01:12PM  
10:19AM  
10:00AM  
09:49AM  
09:34AM  
08:46AM  
07:34AM  
Oct-26-21 08:47AM  
08:32AM  
Oct-25-21 11:31AM  
08:54AM  
Oct-24-21 05:52AM  
Oct-22-21 03:01PM  
10:23AM  
Oct-21-21 10:08PM  
Oct-20-21 02:39PM  
Oct-19-21 07:00AM  
Oct-18-21 01:29PM  
09:02AM  
Oct-17-21 02:31PM  
07:45AM  
Oct-15-21 02:14PM  
11:04AM  
Oct-14-21 07:53PM  
02:37PM  
11:40AM  
10:41AM  
Oct-13-21 02:32PM  
11:50AM  
Oct-12-21 02:30PM  
02:11PM  
11:10AM  
09:27AM  
08:49AM  
08:34AM  
06:57AM  
06:38AM  
06:26AM  
06:16AM  
06:13AM  
05:52AM  
04:50AM  
04:09AM  
03:17AM  
Oct-11-21 11:13AM  
07:06AM  
07:00AM  
Oct-08-21 04:48PM  
02:32PM  
12:25PM  
03:27AM  
Oct-07-21 01:48PM  
10:04AM  
07:42AM  
Oct-06-21 03:11PM  
02:32PM  
01:38PM  
12:33PM  
10:58AM  
07:48AM  
07:00AM  
Oct-05-21 11:10AM  
05:42AM  
Oct-04-21 12:45PM  
12:11PM  
12:00PM  
05:52AM  
Oct-01-21 09:18AM  
Sep-30-21 03:06PM  
Sep-29-21 10:28AM  
09:07AM  
08:44AM  
Sep-28-21 06:11PM  
10:05AM  
09:35AM  
08:52AM  
06:40AM  
02:22AM  
Sep-27-21 02:36PM  
08:50AM  
Sep-24-21 02:02PM  
06:02AM  
06:00AM  
Sep-23-21 05:11PM  
02:22PM  
06:00AM  
06:00AM  
04:23AM  
Sep-22-21 01:43PM  
12:32PM  
06:00AM  
Sep-21-21 11:18AM  
Sep-20-21 01:42PM  
08:12AM  
Sep-18-21 07:03AM  
Sep-17-21 03:59PM  
03:56PM  
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy18.00275,0004,950,0001,007,583Jul 06 04:38 PM
GLAXOSMITHKLINE PLC10% OwnerMay 20Sale12.2532,005,260392,064,4350May 24 05:04 PM